Compare Stocks: OMCL, AMN, WST, and TFX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMN AMN Healthcare Services	$36.40 +1.1%	$32.65	$14.97 ▼ $37.22	$1.40B	0.4	789,078 shs	869,962 shs
OMCL Omnicell	$37.31 +1.4%	$41.15	$29.06 ▼ $55.00	$1.67B	0.98	861,789 shs	529,257 shs
TFX Teleflex	$132.66 -1.7%	$131.83	$100.18 ▼ $145.00	$5.98B	0.81	533,292 shs	585,881 shs
WST West Pharmaceutical Services	$352.19 -0.5%	$343.69	$223.83 ▼ $386.00	$24.92B	1.15	814,533 shs	570,466 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMN AMN Healthcare Services	0.00%	+6.48%	+10.69%	+18.06%	+107.56%
OMCL Omnicell	0.00%	+4.07%	-18.05%	-14.99%	+19.40%
TFX Teleflex	0.00%	-1.62%	-1.03%	+3.53%	+13.44%
WST West Pharmaceutical Services	0.00%	+3.69%	-0.02%	+9.72%	+46.55%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMN AMN Healthcare Services	$36.40 +1.1%	$32.65	$14.97 ▼ $37.22	$1.40B	0.4	789,078 shs	869,962 shs
OMCL Omnicell	$37.31 +1.4%	$41.15	$29.06 ▼ $55.00	$1.67B	0.98	861,789 shs	529,257 shs
TFX Teleflex	$132.66 -1.7%	$131.83	$100.18 ▼ $145.00	$5.98B	0.81	533,292 shs	585,881 shs
WST West Pharmaceutical Services	$352.19 -0.5%	$343.69	$223.83 ▼ $386.00	$24.92B	1.15	814,533 shs	570,466 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMN AMN Healthcare Services	0.00%	+6.48%	+10.69%	+18.06%	+107.56%
OMCL Omnicell	0.00%	+4.07%	-18.05%	-14.99%	+19.40%
TFX Teleflex	0.00%	-1.62%	-1.03%	+3.53%	+13.44%
WST West Pharmaceutical Services	0.00%	+3.69%	-0.02%	+9.72%	+46.55%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMN AMN Healthcare Services	2.22	Hold	$30.86	-15.23% Downside
OMCL Omnicell	2.78	Moderate Buy	$57.86	55.07% Upside
TFX Teleflex	2.42	Hold	$150.50	13.45% Upside
WST West Pharmaceutical Services	3.00	Buy	$368.08	4.51% Upside

Current Analyst Ratings Breakdown

Latest OMCL, AMN, WST, and TFX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/10/2026	TFX Teleflex	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$143.00 ➝ $150.00
8/7/2026	WST West Pharmaceutical Services	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
8/7/2026	AMN AMN Healthcare Services	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$36.00
8/7/2026	AMN AMN Healthcare Services	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$32.00 ➝ $35.00
8/7/2026	TFX Teleflex	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$160.00 ➝ $169.00
8/4/2026	OMCL Omnicell	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C-)
8/3/2026	WST West Pharmaceutical Services	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$400.00 ➝ $412.00
8/3/2026	OMCL Omnicell	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$55.00 ➝ $45.00
7/31/2026	OMCL Omnicell	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$55.00 ➝ $50.00
7/31/2026	TFX Teleflex	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$147.00 ➝ $159.00
7/31/2026	OMCL Omnicell	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$70.00 ➝ $65.00

(Data available from 8/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMN AMN Healthcare Services	$2.73B	0.52	$8.39 per share	4.34	$16.72 per share	2.18
OMCL Omnicell	$1.18B	1.43	$2.80 per share	13.31	$27.45 per share	1.36
TFX Teleflex	$1.99B	2.95	$11.00 per share	12.06	$70.71 per share	1.88
WST West Pharmaceutical Services	$3.07B	8.06	$9.69 per share	36.36	$44.10 per share	7.99

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMN AMN Healthcare Services	-$95.70M	$2.68	13.58	28.44	0.83	3.06%	19.92%	5.93%	N/A
OMCL Omnicell	$2.05M	$0.84	44.42	34.87	1.00	3.13%	5.66%	3.57%	10/29/2026 (Estimated)
TFX Teleflex	-$905.64M	-$23.29	N/A	12.48	0.90	-39.67%	11.93%	5.44%	N/A
WST West Pharmaceutical Services	$493.70M	$7.81	45.09	35.68	2.47	16.98%	20.11%	14.83%	10/22/2026 (Estimated)

Latest OMCL, AMN, WST, and TFX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	AMN AMN Healthcare Services	$0.1888	$0.77	+$0.5812	$0.53	$628.39 million	$673.24 million
8/6/2026	Q2 2026	TFX Teleflex	$1.28	$1.76	+$0.48	$2.28	$559.59 million	$570.33 million
7/30/2026	Q2 2026	OMCL Omnicell	$0.4675	$0.94	+$0.4725	$0.52	$310.21 million	$312.21 million
7/23/2026	Q2 2026	WST West Pharmaceutical Services	$2.08	$2.37	+$0.29	$2.15	$839.98 million	$872.30 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMN AMN Healthcare Services	N/A	N/A	N/A	N/A	N/A
OMCL Omnicell	N/A	N/A	N/A	N/A	N/A
TFX Teleflex	$1.36	1.03%	N/A	N/A	N/A
WST West Pharmaceutical Services	$0.88	0.25%	+5.51%	11.27%	N/A

Latest OMCL, AMN, WST, and TFX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/4/2026	TFX Teleflex	quarterly	$0.34	0.97%	8/14/2026	8/14/2026	9/30/2026
7/21/2026	WST West Pharmaceutical Services	quarterly	$0.22	0.26%	7/29/2026	7/29/2026	8/5/2026
5/15/2026	TFX Teleflex	quarterly	$0.34	1.03%	5/22/2026	5/25/2026	6/30/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMN AMN Healthcare Services	1.00	1.13	1.09
OMCL Omnicell	0.13	1.64	1.43
TFX Teleflex	0.94	2.60	2.12
WST West Pharmaceutical Services	0.07	2.82	2.12

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMN AMN Healthcare Services	99.23%
OMCL Omnicell	97.70%
TFX Teleflex	95.62%
WST West Pharmaceutical Services	93.90%

Insider Ownership

Company	Insider Ownership
AMN AMN Healthcare Services	1.07%
OMCL Omnicell	2.92%
TFX Teleflex	0.70%
WST West Pharmaceutical Services	0.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMN AMN Healthcare Services	2,664	38.79 million	38.37 million	Optionable
OMCL Omnicell	3,580	45.48 million	44.15 million	Optionable
TFX Teleflex	15,500	44.27 million	43.96 million	Optionable
WST West Pharmaceutical Services	10,800	70.38 million	69.95 million	Optionable

OMCL, AMN, WST, and TFX Headlines

Recent News About These Companies

Assenagon Asset Management S.A. Has $23.25 Million Position in West Pharmaceutical Services, Inc. $WST

August 10 at 3:11 AM | marketbeat.com

West Pharmaceutical Services, Inc. $WST Position Reduced by Seilern Investment Management Ltd

August 9 at 5:43 AM | marketbeat.com

Bank of America Corp DE Sells 150,033 Shares of West Pharmaceutical Services, Inc. $WST

August 9 at 3:43 AM | marketbeat.com

Broad-Based Growth Lifted West Pharmaceuticals (WST) in Q2

August 6, 2026 | insidermonkey.com

West Pharmaceutical Services, Inc. (NYSE:WST) Given Consensus Recommendation of "Buy" by Brokerages

August 6, 2026 | marketbeat.com

Redwood Investment Management LLC Makes New Investment in West Pharmaceutical Services, Inc. $WST

August 4, 2026 | marketbeat.com

Is Stronger Q2 Results, Raised Outlook and Buybacks Altering The Investment Case For West Pharmaceutical Services (WST)?

August 3, 2026 | uk.finance.yahoo.com

West Pharmaceutical Services, Inc. $WST Stock Position Trimmed by The Manufacturers Life Insurance Company

August 3, 2026 | marketbeat.com

Cetera Investment Advisers Sells 6,077 Shares of West Pharmaceutical Services, Inc. $WST

August 3, 2026 | marketbeat.com

West Pharmaceutical Services, Inc. $WST Holdings Increased by First Trust Advisors LP

August 3, 2026 | marketbeat.com

California State Teachers Retirement System Has $27.73 Million Position in West Pharmaceutical Services, Inc. $WST

August 2, 2026 | marketbeat.com

Royal Bank of Canada Sells 67,308 Shares of West Pharmaceutical Services, Inc. $WST

August 1, 2026 | marketbeat.com

Amundi Has $161.43 Million Holdings in West Pharmaceutical Services, Inc. $WST

August 1, 2026 | marketbeat.com

Liontrust Investment Partners LLP Decreases Stake in West Pharmaceutical Services, Inc. $WST

July 31, 2026 | marketbeat.com

Quantinno Capital Management LP Increases Stock Holdings in West Pharmaceutical Services, Inc. $WST

July 31, 2026 | marketbeat.com

West Pharmaceutical Services, Inc. $WST Holdings Increased by Dimensional Fund Advisors LP

July 29, 2026 | marketbeat.com

Healthcare of Ontario Pension Plan Trust Fund Has $12.66 Million Stake in West Pharmaceutical Services, Inc. $WST

July 28, 2026 | marketbeat.com

Weiss Asset Management LP Invests $1.99 Million in West Pharmaceutical Services, Inc. $WST

July 27, 2026 | marketbeat.com

Renaissance Technologies LLC Has $52.55 Million Stock Position in West Pharmaceutical Services, Inc. $WST

July 27, 2026 | marketbeat.com

West Pharmaceutical (WST) Signs Decade Long Daikyo Distribution Deal Beyond Japan

July 26, 2026 | finance.yahoo.com

West Pharmaceutical Services, Inc. $WST Shares Acquired by Bank of Nova Scotia

July 26, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

OMCL, AMN, WST, and TFX Company Descriptions

AMN Healthcare Services NYSE:AMN

$36.40 +0.40 (+1.11%)

As of 03:58 PM Eastern

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.

Omnicell NASDAQ:OMCL

$37.31 +0.50 (+1.36%)

As of 04:00 PM Eastern

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Teleflex NYSE:TFX

$132.66 -2.32 (-1.72%)

As of 03:58 PM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

West Pharmaceutical Services NYSE:WST

$352.19 -1.88 (-0.53%)

As of 03:58 PM Eastern

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OMCL, AMN, WST, and TFX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OMCL, AMN, WST, and TFX Earnings

Compare Dividends

Latest OMCL, AMN, WST, and TFX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OMCL, AMN, WST, and TFX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

OMCL, AMN, WST, and TFX Company Descriptions

AMN Healthcare Services NYSE:AMN

Omnicell NASDAQ:OMCL

Teleflex NYSE:TFX

West Pharmaceutical Services NYSE:WST

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OMCL, AMN, WST, and TFX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OMCL, AMN, WST, and TFX Earnings

Compare Dividends

Latest OMCL, AMN, WST, and TFX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OMCL, AMN, WST, and TFX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

OMCL, AMN, WST, and TFX Company Descriptions

AMN Healthcare Services NYSE:AMN

Omnicell NASDAQ:OMCL

Teleflex NYSE:TFX

West Pharmaceutical Services NYSE:WST

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools